Volume 17, Number 4, Juillet-Août 2010Dossier : Lipides marins
|Page(s)||259 - 263|
|Section||Prix de thèse|
|Published online||15 July 2010|
Gastrointestinal lipolysis of lipid-based excipients intended for the oral drug delivery of poorly water-soluble drugs
Gattefossé SAS, 36, chemin de Genas, 69804 Saint-Priest, France
2 Laboratoire d’enzymologie interfaciale et de physiologie de la lipolyse, CNRS UPR 9025, 31, hemin Joseph-Aiguier, 13402 Marseille cedex 20, France
Labrasol® and Gelucire® 44/14 are lipid-based excipients used for the oral drug delivery of poorly water-soluble drugs. These macrogolglycerides are composed of acylglycerols and PEG esters, potential substrates of digestive lipases. We developed an in vitro method to simulate the gastrointestinal lipolysis of these excipients and to evaluate the impact of lipolysis in vivo. At the end of the gastric phase, the composition of both excipients was significantly modified underlining the importance of gastric lipolysis in vivo. We also studied the influence of excipients’ lipolysis on the solubilization of a poorly water-soluble drug, cinnarizine, in aqueous phase. Gastrointestinal lipolysis of Labrasol® was a prerequisite to maintain cinnarizine in aqueous solution, whereas the lipolysis of Gelucire® 44/14 did not affect the cinnarizine solubilization.
Key words: oral drug delivery / gastrointestinal lipolysis / poorly water-soluble drugs / macrogolglycerides / lipases / lipid-based formulations
© John Libbey Eurotext 2010
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.